Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Abitate 250 mg Tablet
Manufacturer/Marketed By : Rpg Life Sciences Ltd
$176.79 $169.99
Abitate 250 mg Tablet is an effective treatment option designed for adult men battling advanced prostate cancer, particularly when the disease has metastasized and previous therapies, such as chemotherapy, have...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Abiraterone Acetate 250 mg
Active Pharmaceutical Ingredient
Abitate 250 mg Tablet
176.79$
169.99$
Abitate 250 mg Tablet is an effective treatment option designed for adult men battling advanced prostate cancer, particularly when the disease has metastasized and previous therapies, such as chemotherapy, have proven ineffective. This medication works synergistically with steroid drugs like prednisone or methylprednisolone to help manage the progression of prostate cancer by inhibiting testosterone production, a hormone that can fuel tumor growth. By lowering testosterone levels, Abitate 250 mg can potentially slow down the spread of cancer, offering patients a valuable tool in their treatment regimen. It is essential for users to be aware of potential side effects and interactions, and to consult their healthcare provider before starting this medication to ensure it aligns with their overall treatment plan. Regular monitoring and follow-up appointments are crucial to assess the effectiveness of Abitate in conjunction with other therapies. If you're considering Abitate 250 mg Tablet, discussing your individual health needs and treatment options with your doctor can help tailor the best approach for managing your prostate cancer. With its targeted action, Abitate represents a hopeful avenue for those facing this challenging diagnosis.
Active Pharmaceutical Ingredient
Uses
• Abitate 250 mg tablet is primarily used in the management of prostate cancer, a prevalent malignancy in men. This medication helps to inhibit the growth of cancerous cells in the prostate gland. Patients may experience symptoms such as difficulty urinating or increased frequency of urination. The use of Abitate 250 mg tablet aims to alleviate these symptoms and improve the quality of life.
• In addition to treating prostate cancer, Abitate 250 mg tablet is beneficial in controlling hormone levels that can affect the progression of the disease. By targeting specific pathways involved in cancer growth, this medication helps to slow down tumor development. Men undergoing treatment with Abitate 250 mg tablet may find it easier to manage their condition. This can lead to a better overall response to therapy.
• Abitate 250 mg tablet can also be utilized as part of a comprehensive treatment plan for advanced prostate cancer. It may be prescribed alongside other therapies to enhance effectiveness and address complex cases. The synergistic effect of Abitate 250 mg tablet with other medications can lead to improved outcomes. This approach is particularly useful for patients with more aggressive forms of cancer.
• Patients receiving Abitate 250 mg tablet are often monitored for their response to treatment. This allows healthcare providers to assess the effectiveness of the medication in managing prostate cancer symptoms. Regular evaluations help in adjusting the treatment plan if necessary. The goal of using Abitate 250 mg tablet is to ensure optimal patient care and symptom management throughout the course of therapy.
Benefits
Abitate 250 mg Tablet decreases the production of testosterone in males. In this way, the cancer cells decrease or stop growing due to low testosterone levels in the body.
How Abitate 250 mg Tablet works can slow the growth of prostate cancer cells and reduce the size of tumors.
Benefits of Abitate 250 mg Tablet can delay the need for other treatments such as chemotherapy or radiation therapy and prolong survival in people with advanced prostate cancer.
Side Effects
Uses of Abitate 250 mg Tablet may cause some side effects. If you experience any of these side effects, contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Urinary tract infection
• Hypokalemia
• Hypertension
• Diarrhoea
• Peripheral oedema
Common Side Effects
• Hypertriglyceridaemia
• Sepsis
• Cardiac failure
• Angina pectoris
• Arrhythmia
• Atrial fibrillation
• Tachycardia
• Dyspepsia (indigestion)
• Rash
• Alanine aminotransferase increased
• Fatigue
• Joint pain
• Hot flashes
• Nausea
How To Use
Abitate 250 mg Tablet taken by mouth once a day on an empty stomach. Do not eat food 2 hours before and 1 hour after taking Abitate 250 mg. Swallow the tablet whole with a full glass of water. Do not crush, chew, or open the tablet. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the next dose at the regular time. Do not take two doses simultaneously to make up for a missed dose.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Abitate 250 mg Tablet. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Abitate 250 mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Abitate 250 mg is recommended. If you experience any side effects please consult your doctor.
• Breastfeeding: It is not recommended to breastfeed while taking Side effects of Abitate 250 mg Tablet. Abitate 250 mg may pass into breast milk and harm the infant. If you are breastfeeding and taking Uses of Abitate 250 mg Tablet, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: It is important to use caution when taking Abitate 250 mg Tablet if you have liver disease, as the dose of the medication may need to be adjusted. It is recommended to consult with your doctor about the appropriate use of this medication in your specific situation.
• Pregnancy: Use of Abitate 250 mg Tablet may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Abitate 250 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Abitate 250 mg Tablet is unlikely to affect your ability to drive or operate machinery. If you experience any side effects while taking Side effects of Abitate 250 mg Tablet, such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.